MedPath

Ammonia N 13

These highlights do not include all the information needed to use AMMONIA N13 INJECTION safely and effectively. See full prescribing information for AMMONIA N13 INJECTION. AMMONIA N13 INJECTION for intravenous use Initial U.S. Approval: 2007

Approved
Approval ID

57947a8c-939e-4468-805c-2f2001041fe4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 25, 2021

Manufacturers
FDA

Massachusetts General Hospital

DUNS: 156293698

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ammonia n-13

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76318-643
Application NumberANDA207025
Product Classification
M
Marketing Category
C73584
G
Generic Name
ammonia n-13
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 24, 2019
FDA Product Classification

INGREDIENTS (3)

AMMONIA N-13Active
Quantity: 37.5 mCi in 1 mL
Code: 9OQO0E343Z
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.